September 2011 Archives

The Sharks have a Secret

| | TrackBacks (0)
Noticed a report in the Daily Mail about how an antibiotic found in sharks could be used as drug to treat human viruses and revolutionise medicine.

Anyone who's listened  to Rockford's Rock Opera audio book and apps will know that 'Creatures Secrets' are fundamental to our story; how losing creatures to extinction is ridding the world of potentially world changing discoveries. Perhaps now, at last, we'll begin to see sharks not a killers, but life savers?

More about sharks' secrets.

The compound, found in the liver of sharks, could be used as a new type of drug to treat a broad spectrum of diseases from dengue and yellow fever to hepatitis B, C and D.  
The antibiotic, squalamine, is already known to be safe for use in humans as an antiviral agent.  

Breakthrough: A compound found in sharks could protect humans from a range of diseases
Dr Michael Zasloff, from Georgetown University who led the study, said: 'To realise that squalamine potentially has broad antiviral properties is immensely exciting, especially since we already know so much from ongoing studies about its behaviour in people.'
 
They found that in both lab and animal experiments squalamine produced antiviral activity against the human pathogens found in the diseases such as some forms of hepatitis which cannot currently be treated. 

Along with offering medical advances this discovery may solve the mystery of how sharks with primitive immune systems can so effectively fight viruses that plague all living creatures. 
Dr Zasloff said: 'I believe squalamine is one of a family of related compounds that protects sharks and some other "primitive" ocean vertebrates, such as the sea lamprey, from viruses.
'Squalamine appears to protect against viruses that attack the liver and blood tissues, and other similar compounds that we know exist in the shark likely protect against respiratory viral infections, and so on.
'We may be able to harness the shark's novel immune system to turn all of these antiviral compounds into agents that protect humans against a wide variety of viruses.
'That would be revolutionary. While many antibacterial agents exist, doctors have few antiviral drugs to help their patients, and few of those are broadly active.'
Dr Zasloff discovered squalamine in 1993 and it has already been used in clinical trials to treat cancer and several eye disorders. 
'I was interested in sharks because of their seemingly primitive but effective immune system. No one could explain why the shark was so hardy,' he said.

Water interesting discovery: The study may solve the mystery of how sharks with primitive immune systems can so effectively fight viruses that plague all living creatures
When he started to 'play' with the compound he found that it inhibited the growth of rapidly growing blood vessels, such as those found in tumour growth and certain retinal diseases. 
Since 1995 it has been synthesised in the laboratory rather than taking any natural shark tissue. 
Dr Zasloff remained interested in how the natural cholesterol type molecule, which has a net positive electrical charge, acted as an immune agent in sharks.
When it enters cells, and it can only access certain cells including those in blood vessels, capillaries and the liver, squalamine 'kicks off' positively-charged proteins that are bound to the negatively charged surface of the cells inner membrane.
Some of these displaced proteins are used by viruses to replicate and without the protein a virus's life cycle is disrupted, the microbe is rendered inert and the cell containing it is destroyed. 
This means that squalamine seems to be designed to fight certain viral infections, Dr Zasloff claimed. 
He said: 'To me, the key to squalamine is that once in the body it times its action to match the life cycle of most viruses.
'Most viruses take hours to complete their life cycle, the same time period that squalamine renders tissues and organs viral resistant after administration. 
'In addition, it acts fast to stop viral replication, clearing the body of these predators within hours.
'Furthermore, because squalamine acts by making the host's tissues less receptive for infection, rather than by targeting a specific viral protein, the emergence of viral resistance would not be anticipated.'
In tissue culture studies squalamine was shown to inhibit the infection of human blood vessel cells by the dengue virus and human liver cells infected with hepatitis B and D, which can cause liver failure and cancer.
In animal studies, scientists from across the USA discovered that squalamine controlled infections of yellow fever, Eastern equine encephalitis virus, and murine cytomegalovirus, and in some cases cured the animals.
The study was published in the Proceedings of the National Academy of Sciences Early Edition online.


Original Story: http://www.dailymail.co.uk/health/article-2039323/An-antibiotic-liver-sharks-revolutionise-human-medicine.html#ixzz1YVV2cXMa

About this Archive

This page is an archive of entries from September 2011 listed from newest to oldest.

August 2011 is the previous archive.

November 2011 is the next archive.

Find recent content on the main index or look in the archives to find all content.